156 related articles for article (PubMed ID: 22310608)
1. Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report.
Zhao T; Yang C; Xue Y; Qiu YY; Hu L; Qiu Y; Wang X; Yang B; Rong R; Xu M; Zhu T
Transplant Proc; 2012 Jan; 44(1):175-8. PubMed ID: 22310608
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
[TBL] [Abstract][Full Text] [Related]
3. [Regulatory T cells in kidney transplant recipients].
Libetta C; Portalupi V; Margiotta E; Sepe V; Canevari M; Meloni F; Morosini M; Dal Canton A
G Ital Nefrol; 2009; 26 Suppl 45():S54-7. PubMed ID: 19382095
[TBL] [Abstract][Full Text] [Related]
4. Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation.
Wang Z; Shi BY; Qian YY; Cai M; Wang Q
Clin Exp Immunol; 2009 Mar; 155(3):496-503. PubMed ID: 19141125
[TBL] [Abstract][Full Text] [Related]
5. The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients.
Bouvy AP; Klepper M; Kho MM; Boer K; Betjes MG; Weimar W; Baan CC
Nephrol Dial Transplant; 2014 Aug; 29(8):1587-97. PubMed ID: 24771499
[TBL] [Abstract][Full Text] [Related]
6. Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation.
Vondran FW; Timrott K; Tross J; Kollrich S; Schwarz A; Lehner F; Klempnauer J; Becker T; Schwinzer R
Transpl Int; 2010 May; 23(5):514-23. PubMed ID: 19951265
[TBL] [Abstract][Full Text] [Related]
7. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody.
Vignali D; Gürth CM; Pellegrini S; Sordi V; Sizzano F; Piemonti L; Monti P
Transplantation; 2016 Sep; 100(9):1853-61. PubMed ID: 27306531
[TBL] [Abstract][Full Text] [Related]
8. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
Lin WX; Christiansen D; Fu LL; Roberts MA; Sandrin MS; Ierino FL
Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
[TBL] [Abstract][Full Text] [Related]
9. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
[TBL] [Abstract][Full Text] [Related]
10. Quantification of circulating regulatory T cells by flow cytometry in kidney transplant patients after basiliximab induction therapy.
Abadja F; Alamartine E; Berthoux F; Mariat C; Genin C; Lambert C
Transplantation; 2010 Feb; 89(3):366-8. PubMed ID: 20145530
[No Abstract] [Full Text] [Related]
11. Evaluation of CD4
McRae JL; Chia JS; Pommey SA; Dwyer KM
Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporin but not everolimus inhibits chemokine receptor expression on CD4+ T cell subsets circulating in the peripheral blood of renal transplant recipients.
Hoerning A; Köhler S; Jun C; Lu J; Fu J; Tebbe B; Dolff S; Feldkamp T; Kribben A; Hoyer PF; Witzke O
Clin Exp Immunol; 2012 May; 168(2):251-9. PubMed ID: 22471287
[TBL] [Abstract][Full Text] [Related]
13. Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance.
Krepsova E; Tycova I; Sekerkova A; Wohlfahrt P; Hruba P; Striz I; Sawitzki B; Viklicky O
BMC Nephrol; 2015 Aug; 16():146. PubMed ID: 26286066
[TBL] [Abstract][Full Text] [Related]
14. CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H.
Bloom DD; Chang Z; Fechner JH; Dar W; Polster SP; Pascual J; Turka LA; Knechtle SJ
Am J Transplant; 2008 Apr; 8(4):793-802. PubMed ID: 18261176
[TBL] [Abstract][Full Text] [Related]
15. Clinical rejection and persistent immune regulation in kidney transplant patients.
Hendrikx TK; Klepper M; Ijzermans J; Weimar W; Baan CC
Transpl Immunol; 2009 Jul; 21(3):129-35. PubMed ID: 19398001
[TBL] [Abstract][Full Text] [Related]
16. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
[TBL] [Abstract][Full Text] [Related]
17. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells.
Morales J; Bono MR; Fierro A; Iñiguez R; Zehnder C; Rosemblatt M; Calabran L; Herzog C; Benavente D; Aguiló J; Pefaur J; Alba A; Ferrario M; Simon W; Contreras L; Buckel E
Transplant Proc; 2008 Nov; 40(9):3223-8. PubMed ID: 19010240
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.
Vallotton L; Hadaya K; Venetz JP; Buehler LH; Ciuffreda D; Nseir G; Codarri L; Villard J; Pantaleo G; Pascual M
Clin J Am Soc Nephrol; 2011 Aug; 6(8):2025-33. PubMed ID: 21757642
[TBL] [Abstract][Full Text] [Related]
19. Comparison of regulatory T cells and FoxP3-positive T-cell subsets in the peripheral blood of renal transplant recipients with sirolimus versus cyclosporine: a preliminary study.
Zhao T; Yang C; Qiu Y; Xue Y; Zhao Z; Song D; Qiu Y; Ma Z; Yang B; Xu M; Rong R; Zhu T
Transplant Proc; 2013; 45(1):148-52. PubMed ID: 23375289
[TBL] [Abstract][Full Text] [Related]
20. Dynamic analysis of B-cell subsets in de novo living related kidney transplantation with induction therapy of basiliximab.
Longshan L; Dongwei L; Qian F; Jun L; Suxiong D; Yitao Z; Yunyi X; Huiting H; Lizhong C; Jiguang F; Changxi W
Transplant Proc; 2014; 46(2):363-7. PubMed ID: 24655964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]